Feasibility study to treat lung cancer with the permanently implantable LDR CivaSheet

Brief description of study

If you have been diagnosed with non-smail cell lung cancer (NSCLC), you may qualify for this study evaluating the usefulness of the brachytherapy source - CivaSheet®. The main goal of this study is to evaluate the usefulness of a brachytherapy device (the insertion of radioactive implants into the tissue) which is designed to deliver the radiation source targeted directly to the tumor.

Clinical Study Identifier: s17-01418
ClinicalTrials.gov Identifier: NCT03290534
Principal Investigator: Michael Zervos.

If you are registered as a volunteer, please log in to contact the study team/express interest in this study.

Contact the research team to learn more about this study.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.